Illumina panel reagent kits
Active Awarded Last action
- Contract number
- 75N98026F00002
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $210,284
Award facts
- Opportunity
-
- 75N98026Q00071 Solicitation number
- Contract value 100% obligated
- $210,283.65 Current and potential, with all options
- Completion date 65% complete
- Current and potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Westlake, MD 20817, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Office of the Director (civilian agency) awarded a delivery order valued at $210,283.65 to Illumina, Inc. for Illumina Panel Reagent Kits on February 27, 2026, with an ultimate completion date of February 26, 2027. This firm fixed-price delivery order, which includes no set-aside designation, will be performed in Westlake, Maryland. Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, will deliver reagent kits that support the agency's genomic research and diagnostic capabilities.
This delivery order represents a continuation of Illumina's established role as a critical provider of sequencing reagents and consumables across the federal government. The company maintains a substantial $45 million indefinite delivery contract with the U.S. Department of Agriculture through June 2030 and has received numerous awards from agencies including the National Institutes of Health, Department of Veterans Affairs, National Cancer Institute, and Food and Drug Administration. The firm fixed-price structure and non-competitive nature of this award reflect Illumina's position as the specialized, single-source provider of its proprietary sequencing technologies and associated reagent kits, which are essential to federal genomic research, infectious disease surveillance, cancer diagnostics, and agricultural genetic analysis initiatives.
Quick answers
Who was awarded contract 75N98026F00002?
75N98026F00002 was awarded to Illumina, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on February 27, 2026.
How much is contract 75N98026F00002 worth?
The government has obligated $210,284 on 75N98026F00002.
Which agency awarded contract 75N98026F00002?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026F00002, with funding from Office of the Director (National Institutes of Health).
Is contract 75N98026F00002 an order under another contract?
Yes. 75N98026F00002 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N98026F00002 competed?
The extent of competition for 75N98026F00002 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award